Respect++ Gaurav sir, I mentioned about BIOCON on you session on 5th October. You invested time to actually analyse it all and bring out such detailed video 😇😇😇
Condolences to Kiran Mazumdar Shaw for the death of her husband. But full credit to her for being a woman and making 2 well known pharma companies. May she have the strength to overcome the loss.
viatris deal will make them completely vertically integrated from labs to market . I feel biocon suffered all these years because of a weak partner in Mylan ( now viatris ) , Pfizer being the main promoter of viatris was least interested in marketing transtuzumab and pegfilgastrim as they had their own biosimilars launched in US market . It makes sense for biocon to acquire the marketing rights of all these assets , as it can help for market share growth. COVID took away 2 crucial years from them , as research work and fda inspections came to a stand still. diabetes and oncology segments are growing exponentially where they have a big advantage , according to me only big concern for biocon is does the promoter have a proper inheritance plan in place. if managed properly biocon can lead India to a big biotech (biological) boom
Sir, Thank you Very much for the useful information. I am holding it for last 4- 5 years and was confused what is wrong and what to do with this stock. Now I can take my decision.
Gaurav sir good video reflecting concerns of many investors.. It's important to reflect some companies are easy to understand and give predictable results.others are not taking the beaten path and hence will always be doubted and questioned...
It is worst , rightly said but also much hyped stock. Further Ms Kiran Majumdar Shaw is called by many news channel for discussing anything about Pharma industry. No anchor hass shown guts why her own company doing so badly!
Hi Gaurav, First of all, I would like to appreciate your efforts in educating us about financial markets. Could you please make videos on the forex market and commodities market and their impact on the securities
Your analysis very superficial. Pharma biz takes a lot of time to launch products. ROCE in the initial years can be quite misleading as that is full of investment Phase (R&D)
Keep< up the great work. The market price can best be described by logarithmic regression in my own opinion, these kinds of ups and downs are nothing new from the ATH last crash and the previous bottom. FLOYD JOHNSON is doing a great job with his signals as I've been able to accumulate over 11btc from July till date. He's a pro in the crypto space and I'm no longer bothered about if the market keeps going bearish..
Respect++ Gaurav sir,
I mentioned about BIOCON on you session on 5th October. You invested time to actually analyse it all and bring out such detailed video 😇😇😇
Condolences to Kiran Mazumdar Shaw for the death of her husband. But full credit to her for being a woman and making 2 well known pharma companies. May she have the strength to overcome the loss.
not only Biocon but also Wockpharma, Auropharma, Jublient Pharma too
What about Auropharma now😂
Do not worry about warning letter and recent observations of sites, they will comply,..
Now in 2024 BIOCON Target 350+🎯
viatris deal will make them completely vertically integrated from labs to market . I feel biocon suffered all these years because of a weak partner in Mylan ( now viatris ) , Pfizer being the main promoter of viatris was least interested in marketing transtuzumab and pegfilgastrim as they had their own biosimilars launched in US market . It makes sense for biocon to acquire the marketing rights of all these assets , as it can help for market share growth. COVID took away 2 crucial years from them , as research work and fda inspections came to a stand still. diabetes and oncology segments are growing exponentially where they have a big advantage , according to me only big concern for biocon is does the promoter have a proper inheritance plan in place. if managed properly biocon can lead India to a big biotech (biological) boom
Sirji please make a video on Piramal Pharma
ban gaya
Sir please make a video about Narayana Hrudayslaya
Yes , do the analysis for Piramal Pharma...
Sir, Thank you Very much for the useful information. I am holding it for last 4- 5 years and was confused what is wrong and what to do with this stock. Now I can take my decision.
What taken holding or exit??
Is buying more a good option?
Gaurav sir good video reflecting concerns of many investors.. It's important to reflect some companies are easy to understand and give predictable results.others are not taking the beaten path and hence will always be doubted and questioned...
I feel Ms Kiran Majumdar is more concerned about her PR and relation with media than running her company.
Kiran madam has many firsts to her credit ...many of which highlighted by others .. the good times will play out for sure !!
It is worst , rightly said but also much hyped stock. Further Ms Kiran Majumdar Shaw is called by many news channel for discussing anything about Pharma industry. No anchor hass shown guts why her own company doing so badly!
Overhyped,corruption and bad governance
Sir, a video on Piramal Pharma please
Wait and watch on Monday market me price 202 now I want to purchase at 182-195.....is it good to purchase at that price....Pl suggest....
Thank you for the detail analysis of Biocon. Please prepare a video on Dr Reddy Laboratories also..!!
Hi Gaurav,
First of all, I would like to appreciate your efforts in educating us about financial markets. Could you please make videos on the forex market and commodities market and their impact on the securities
Pleased review TTK PRESTIGE
View on Piramal Pharma and Piramal industries sir
Ek video ispe bhi !
Why hdfc bank is worst performing banking stock
How much biocon can earn front viatris stake which biocon has recently purchased
Would you suggest Hold on Biocon for next 5 years to a long-term investor.
Now I brought biocon long term (1 year)Is it correct,?
Can you analyse Zydus lifesciences
sir make a video on strides pharma it's running at a 6 month low does this company create value related products
Thank you for the video
Sir what's you views on CIPLA ?
Please a complete review on CIPLA.
Thanks in advance
Hi sir I m buy biocon CMP 414 , Abhi my kya Karun
मत बेचना abhi
Sir make a video on Aurobindo Pharma please 🙏
Sir mere pass 500 share he hold kate ki sold suggest
Today biocon at rate 200/ so hold or sale
Sir i have buy 527 share at Rs 314. So, what will you suggest?
@@vineetjangra4199 don't sell
nice sir thank you
Plz sir stride pharma ka detail analysis 🙏
Bas smallcase walon diwali chala gya muhurat trading ka ad band kar do
Sir mere pas 273rs ta 170 stock hai. Avi 5500 loss hai. Kya kare
Kya kiya tha?
Should we sell
Wbt jubilant pharma
Plz review tanla
ITS GOING TO BE ZERO SOON. MOVE FORWARD
Your analysis very superficial. Pharma biz takes a lot of time to launch products. ROCE in the initial years can be quite misleading as that is full of investment Phase (R&D)
Shukra huzur,
Keep< up the great work. The market price can best be described by logarithmic regression in my own opinion, these kinds of ups and downs are nothing new from the ATH last crash and the previous bottom. FLOYD JOHNSON is doing a great job with his signals as I've been able to accumulate over 11btc from July till date. He's a pro in the crypto space and I'm no longer bothered about if the market keeps going bearish..
Please